Crossmark

Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells

Crossref DOI link: https://doi.org/10.1016/j.clinsp.2024.100422

Published Print: 2024-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Carvalho, Maria Fernanda Lopes

Calicchio, Carolina Santana

de Almeida, Bruna Oliveira

de Miranda, Livia Bassani Lins

Lipreri da Silva, Jean Carlos

Lima, Keli

Machado-Neto, João Agostinho https://orcid.org/0000-0002-2937-8109
Funding

Funding for this research was provided by:

State of Sao Paulo Research Foundation (2020/12842-0)

State of Sao Paulo Research Foundation (2022/11038-8)

State of Sao Paulo Research Foundation (2022/14505-6)

State of Sao Paulo Research Foundation (2019/23864-7)

State of Sao Paulo Research Foundation (2023/12246-6)

State of Sao Paulo Research Foundation (2022/03316-8)

State of Sao Paulo Research Foundation (2020/12909-7)

State of Sao Paulo Research Foundation (2021/11606-3)

Coordination of Higher Education Personnel Improvement
License Information

Text and Data Mining valid from 2024-01-01

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2024-06-17
More Information

This article is maintained by: Elsevier

Article Title: Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2024.100422

Content Type: article

Copyright: © 2024 HCFMUSP. Published by Elsevier España, S.L.U.